Korean J Pediatr.  2015 Apr;58(4):123-128. 10.3345/kjp.2015.58.4.123.

Osteosarcoma in Korean children and adolescents

Affiliations
  • 1Department of Pediatrics, Korea Cancer Center Hospital, Seoul, Korea. junahlee@kcch.re.kr

Abstract

Osteosarcoma is the most frequent primary bone tumor. Advances in combination chemotherapy and surgical technique have greatly improved the survival of patients with osteosarcoma. In Korea, improvements in osteosarcoma treatment have been made over the past two decades. The 5-year event-free survival rate of Korean children and adolescents with localized disease is 64.6%, comparable to that of American or European patients. This article provides an overview of current therapies for osteosarcoma in Korea.

Keyword

Osteosarcoma; Korea; Child; Adolescents

MeSH Terms

Adolescent*
Child*
Disease-Free Survival
Drug Therapy, Combination
Humans
Korea
Osteosarcoma*
Full Text Links
  • KJP
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr